Cargando…

Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?

BACKGROUND: Neuroblastoma is a common solid tumor of childhood and is often associated with hypertension. Potential etiologies contributing to hypertension include renal compression, pain, volume overload, and catecholamine secretion. CASES: We completed a single center retrospective review of child...

Descripción completa

Detalles Bibliográficos
Autores principales: Harding, Matthew, Deyell, Rebecca J., Blydt‐Hansen, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351666/
https://www.ncbi.nlm.nih.gov/pubmed/34612613
http://dx.doi.org/10.1002/cnr2.1569
_version_ 1784762483480723456
author Harding, Matthew
Deyell, Rebecca J.
Blydt‐Hansen, Tom
author_facet Harding, Matthew
Deyell, Rebecca J.
Blydt‐Hansen, Tom
author_sort Harding, Matthew
collection PubMed
description BACKGROUND: Neuroblastoma is a common solid tumor of childhood and is often associated with hypertension. Potential etiologies contributing to hypertension include renal compression, pain, volume overload, and catecholamine secretion. CASES: We completed a single center retrospective review of children with neuroblastoma and ≥stage II hypertension (per Hypertension Canada guidelines) over a 2‐year period. All patients (n = 10) had elevated urine normetanephrine levels and eight had intra‐abdominal tumors. Four patients had refractory hypertension requiring > three agents, of which three required alpha/beta blockade. CONCLUSION: Although multifactorial, hypertension in neuroblastoma often has a neuroendocrine component. Excess normetanephrine production in neuroblastoma may be a more common hypertensive mechanism than previously appreciated. Urinary normetanephrine elevation could suggest potential neuroendocrine‐mediated hypertension.
format Online
Article
Text
id pubmed-9351666
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93516662022-08-09 Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease? Harding, Matthew Deyell, Rebecca J. Blydt‐Hansen, Tom Cancer Rep (Hoboken) Case Reports BACKGROUND: Neuroblastoma is a common solid tumor of childhood and is often associated with hypertension. Potential etiologies contributing to hypertension include renal compression, pain, volume overload, and catecholamine secretion. CASES: We completed a single center retrospective review of children with neuroblastoma and ≥stage II hypertension (per Hypertension Canada guidelines) over a 2‐year period. All patients (n = 10) had elevated urine normetanephrine levels and eight had intra‐abdominal tumors. Four patients had refractory hypertension requiring > three agents, of which three required alpha/beta blockade. CONCLUSION: Although multifactorial, hypertension in neuroblastoma often has a neuroendocrine component. Excess normetanephrine production in neuroblastoma may be a more common hypertensive mechanism than previously appreciated. Urinary normetanephrine elevation could suggest potential neuroendocrine‐mediated hypertension. John Wiley and Sons Inc. 2021-10-06 /pmc/articles/PMC9351666/ /pubmed/34612613 http://dx.doi.org/10.1002/cnr2.1569 Text en © 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Harding, Matthew
Deyell, Rebecca J.
Blydt‐Hansen, Tom
Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?
title Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?
title_full Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?
title_fullStr Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?
title_full_unstemmed Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?
title_short Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?
title_sort catecholamines in neuroblastoma: driver of hypertension, or solely a marker of disease?
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351666/
https://www.ncbi.nlm.nih.gov/pubmed/34612613
http://dx.doi.org/10.1002/cnr2.1569
work_keys_str_mv AT hardingmatthew catecholaminesinneuroblastomadriverofhypertensionorsolelyamarkerofdisease
AT deyellrebeccaj catecholaminesinneuroblastomadriverofhypertensionorsolelyamarkerofdisease
AT blydthansentom catecholaminesinneuroblastomadriverofhypertensionorsolelyamarkerofdisease